These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2365274)

  • 1. [The development of radioimmunoassay and studies of removal system for advanced glycosylation endproduct].
    Kato M
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):152-60. PubMed ID: 2365274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radioimmunoassay for an advanced glycosylation endproduct.
    Nakayama H; Kato M; Makita Z; Aoki S; Kuroda Y; Misawa K; Yanagisawa K; Nakagawa S; Ikeda K
    J Immunol Methods; 1988 Aug; 112(1):57-61. PubMed ID: 3403989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of an advanced glycosylation product bound to protein in situ.
    Chang JC; Ulrich PC; Bucala R; Cerami A
    J Biol Chem; 1985 Jul; 260(13):7970-4. PubMed ID: 4008486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against in vivo presence of 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole, a major fluorescent advanced end product generated by nonenzymatic glycosylation.
    Horiuchi S; Shiga M; Araki N; Takata K; Saitoh M; Morino Y
    J Biol Chem; 1988 Dec; 263(35):18821-6. PubMed ID: 3198601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells.
    Vlassara H; Valinsky J; Brownlee M; Cerami C; Nishimoto S; Cerami A
    J Exp Med; 1987 Aug; 166(2):539-49. PubMed ID: 3598465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of formation of the putative advanced glycosylation end product and protein cross-link 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole.
    Njoroge FG; Fernandes AA; Monnier VM
    J Biol Chem; 1988 Aug; 263(22):10646-52. PubMed ID: 3392032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo.
    Obayashi H; Nakano K; Shigeta H; Yamaguchi M; Yoshimori K; Fukui M; Fujii M; Kitagawa Y; Nakamura N; Nakamura K; Nakazawa Y; Ienaga K; Ohta M; Nishimura M; Fukui I; Kondo M
    Biochem Biophys Res Commun; 1996 Sep; 226(1):37-41. PubMed ID: 8806589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose.
    Pongor S; Ulrich PC; Bencsath FA; Cerami A
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2684-8. PubMed ID: 6585821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end product (AGE): characterization of the products from the reaction between D-glucose and serum albumin.
    Wu JT; Tu MC; Zhung P
    J Clin Lab Anal; 1996; 10(1):21-34. PubMed ID: 8926563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
    Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
    J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collisional spectroscopy as a screening procedure for the determination of 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole from acid hydrolysis of B-poly(L-lysine) and B-albumin.
    Pelli B; Sturaro A; Traldi P; Lapolla A; Poli T; Fedele D; Crepaldi G
    Biomed Environ Mass Spectrom; 1988 Jan; 15(1):7-11. PubMed ID: 3349208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of advanced glycosylation products in complications of diabetes.
    Cerami A; Vlassara H; Brownlee M
    Diabetes Care; 1988; 11 Suppl 1():73-9. PubMed ID: 3069394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of brown product FFI in nondiabetic and diabetic rat collagen.
    Lapolla A; Gerhardinger C; Pelli B; Sturaro A; Del Favero E; Traldi P; Crepaldi G; Fedele D
    Diabetes; 1990 Jan; 39(1):57-61. PubMed ID: 2210060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells.
    Stitt AW; He C; Vlassara H
    Biochem Biophys Res Commun; 1999 Mar; 256(3):549-56. PubMed ID: 10080935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits.
    Palinski W; Koschinsky T; Butler SW; Miller E; Vlassara H; Cerami A; Witztum JL
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):571-82. PubMed ID: 7749871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products.
    Radoff S; Vlassara H; Cerami A
    Arch Biochem Biophys; 1988 Jun; 263(2):418-23. PubMed ID: 3377512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein glycation: creation of catalytic sites for free radical generation.
    Yim MB; Yim HS; Lee C; Kang SO; Chock PB
    Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose.
    Nakamura K; Nakazawa Y; Ienaga K
    Biochem Biophys Res Commun; 1997 Mar; 232(1):227-30. PubMed ID: 9125137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules.
    Vlassara H; Brownlee M; Cerami A
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5588-92. PubMed ID: 2994035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: role in diabetes and aging.
    Vlassara H; Brownlee M; Cerami A
    Prog Clin Biol Res; 1989; 304():205-18. PubMed ID: 2550952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.